8 remarkable things we achieved together in 2019, and recent years Date 17 December 2019 2019 was another exciting year of progress. Here are 8 of the highlights, and 8 ways you can still get involved.
Progress in gene therapy treatment for Parkinson's Date 5 December 2019 Researchers, funded by Parkinson's UK, have produced positive results in mice for a gene therapy treatment that directly targets the production of the alpha-synuclein protein.
New report shows people with advanced or terminal illness support law change on assisted dying Date 19 November 2019 Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying
Could sleep boost waste disposal in the brain and prevent Parkinson’s? Date 1 November 2019 Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Scotland’s hospitals fail to give people with Parkinson’s medication on time more than 100,000 times each year Date 24 October 2019 The report, Get It On Time, highlights systematic failures in Scotland’s hospitals that mean that people with Parkinson’s don’t receive their vital medication at their prescribed times.
Revolutionary research advocate Ken Bowler dies aged 76 Date 23 October 2019 The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
Ex-footballers more likely to get Parkinson's, research finds Date 22 October 2019 Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
Cannabis and Parkinson's: your views Date 14 October 2019 Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
Can cannabis stop Parkinson's hallucinations? Date 14 October 2019 A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
Promising results from a phase II study for people with early-stage Parkinson’s Date 8 October 2019 A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
